Cargando…

Role of Lipids and Apolipoproteins in Predicting the Prognosis of Hepatocellular Carcinoma After Resection

PURPOSE: To further clarify the association between abnormal levels of serum lipid components as the main features of dyslipidaemia and hepatocellular carcinoma, which remains unclear. PATIENTS AND METHODS: We examined the serum level of lipids and apolipoproteins pattern in 471 patients undergoing...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ni, Xiao-Chun, Yi, Yong, Fu, Yi-Peng, Cai, Xiao-Yan, Liu, Gao, Huang, Jin-Long, Gan, Wei, Xu, Jie, Qiu, Shuang-Jian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7756018/ https://www.ncbi.nlm.nih.gov/pubmed/33376344 http://dx.doi.org/10.2147/OTT.S279997

Ejemplares similares

Down-regulation of sirtuin 3 is associated with poor prognosis in hepatocellular carcinoma after resection
por: Wang, Jia-Xing, et al.
Publicado: (2014)

Apolipoprotein A1: a novel serum biomarker for predicting the prognosis of hepatocellular carcinoma after curative resection
por: Ma, Xiao-Lu, et al.
Publicado: (2016)

Overexpression of interleukin-35 associates with hepatocellular carcinoma aggressiveness and recurrence after curative resection
por: Fu, Yi-Peng, et al.
Publicado: (2016)

Overexpression of CD39 in hepatocellular carcinoma is an independent indicator of poor outcome after radical resection
por: Cai, Xiao-Yan, et al.
Publicado: (2016)

Combination of Intratumoral Invariant Natural Killer T Cells and Interferon-Gamma Is Associated with Prognosis of Hepatocellular Carcinoma after Curative Resection
por: Xiao, Yong-Sheng, et al.
Publicado: (2013)

A Novel and Validated Inflammation-Based Score (IBS) Predicts Survival in Patients With Hepatocellular Carcinoma Following Curative Surgical Resection: A STROBE-Compliant Article
por: Fu, Yi-Peng, et al.
Publicado: (2016)

Lipids, apolipoproteins, and prognosis of amyotrophic lateral sclerosis
por: Ingre, Caroline, et al.
Publicado: (2020)

Systemic Hepatic-Damage Index for Predicting the Prognosis of Hepatocellular Carcinoma after Curative Resection
por: Gao, Xing-hui, et al.
Publicado: (2017)

Prognostic impact of lactic dehydrogenase to albumin ratio in hepatocellular carcinoma patients with Child–Pugh I who underwent curative resection: a prognostic nomogram study
por: Gan, Wei, et al.
Publicado: (2018)

Prognostic Value of the Modified Glasgow Prognostic Score in Patients Undergoing Radical Surgery for Hepatocellular Carcinoma
por: Ni, Xiao-Chun, et al.
Publicado: (2015)

Combined preoperative albumin-bilirubin (ALBI) and serum γ-glutamyl transpeptidase (GGT) predicts the outcome of hepatocellular carcinoma patients following hepatic resection
por: Zhang, Chi-Hao, et al.
Publicado: (2019)

Impact of apolipoprotein A1 on tumor immune microenvironment, clinical prognosis and genomic landscape in hepatocellular carcinoma
por: Wang, Ying, et al.
Publicado: (2023)

Effects of isoflavones on lipid and apolipoprotein levels in patients with type 2 diabetes in Heilongjiang Province in China
por: Chi, Xiao-Xing, et al.
Publicado: (2016)

High expression of IL-17 and IL-17RE associate with poor prognosis of hepatocellular carcinoma
por: Liao, Rui, et al.
Publicado: (2013)

Prognostic nomogram for patients with hepatocellular carcinoma underwent adjuvant transarterial chemoembolization following curative resection
por: Jing, Chu-Yu, et al.
Publicado: (2017)

High expression of 5-hydroxymethylcytosine and isocitrate dehydrogenase 2 is associated with favorable prognosis after curative resection of hepatocellular carcinoma
por: Liu, Wei-Ren, et al.
Publicado: (2014)

Inflammation-nutrition scope predicts prognosis of early-stage hepatocellular carcinoma after curative resection
por: Zhu, Ying, et al.
Publicado: (2017)

NSUN5 promotes progression and predicts poor prognosis in hepatocellular carcinoma
por: Zhang, Xiao-Wen, et al.
Publicado: (2022)

Meta-analysis of surgical resection and radiofrequency ablation for early hepatocellular carcinoma
por: Xu, Gang, et al.
Publicado: (2012)

Elevated apolipoprotein B predicts poor postsurgery prognosis in patients with hepatocellular carcinoma
por: Yan, Xiaotong, et al.
Publicado: (2019)

Decreased Expression of GATA2 Promoted Proliferation, Migration and Invasion of HepG2 In Vitro and Correlated with Poor Prognosis of Hepatocellular Carcinoma
por: Li, Yi-Wei, et al.
Publicado: (2014)

Serum apolipoprotein E concentration and polymorphism influence serum lipid levels in Chinese Shandong Han population
por: Han, ShuYi, et al.
Publicado: (2016)

High expression of Oct4 and Nanog predict poor prognosis in intrahepatic cholangiocarcinoma patients after curative resection
por: Zhang, Mei-xia, et al.
Publicado: (2019)

A six lipid metabolism related gene signature for predicting the prognosis of hepatocellular carcinoma
por: Xu, Kequan, et al.
Publicado: (2022)

Fibrinogen and C-reactive protein score is a prognostic index for patients with hepatocellular carcinoma undergoing curative resection: a prognostic nomogram study
por: Gan, Wei, et al.
Publicado: (2018)

Circulating Lipoprotein Lipids, Apolipoproteins and Ischemic Stroke
por: Yuan, Shuai, et al.
Publicado: (2020)

The preoperative platelet to albumin ratio predicts the prognosis of hepatocellular carcinoma patients without portal hypertension after liver resection
por: Li, Chuan, et al.
Publicado: (2019)

Apolipoprotein C-I Polymorphism and Its Association with Serum Lipid Levels and Longevity in the Bama Population
por: Li, You, et al.
Publicado: (2017)

Does Chronic Kidney Disease Really Affect the Complications and Prognosis After Liver Resection for Hepatocellular Carcinoma? A Meta-Analysis
por: Liu, Xiao-Yu, et al.
Publicado: (2022)

Yirui Capsules Alleviate Atherosclerosis by Improving the Lipid Profile and Reducing Inflammation in Apolipoprotein E-Deficient Mice
por: Xu, Jiqu, et al.
Publicado: (2018)

Carbohydrate, Lipid, and Apolipoprotein Biomarkers in Blood and Risk of Thyroid Cancer: Findings from the AMORIS Cohort
por: Xiao, Xue, et al.
Publicado: (2023)

Positive expression of Midkine predicts early recurrence and poor prognosis of initially resectable combined hepatocellular cholangiocarcinoma
por: Ma, Ming-Chun, et al.
Publicado: (2018)

Comparison of prognosis between surgical resection and transarterial chemoembolization for patients with solitary huge hepatocellular carcinoma
por: Wei, Cheng-Yi, et al.
Publicado: (2020)

Percutaneous radiofrequency ablation is superior to hepatic resection in patients with small hepatocellular carcinoma
por: Zhang, Yan-Hua, et al.
Publicado: (2020)

Comprehensive analysis and validation of SNX7 as a novel biomarker for the diagnosis, prognosis, and prediction of chemotherapy and immunotherapy response in hepatocellular carcinoma
por: Chen, Jianlin, et al.
Publicado: (2023)

Prognosis after resection of single large hepatocellular carcinoma: Results from an Asian high-volume liver surgery center
por: Liu, Yueh-Wei, et al.
Publicado: (2020)

Apolipoproteins and cancer
por: Ren, Liwen, et al.
Publicado: (2019)

Emerging evidences for the opposite role of apolipoprotein C3 and apolipoprotein A5 in lipid metabolism and coronary artery disease
por: Dai, Wen, et al.
Publicado: (2019)

Serum Lipids, Apolipoproteins, and Mortality among Coronary Artery Disease Patients
por: Ding, Ding, et al.
Publicado: (2014)

Lenvatinib plus anti-PD-1 therapy represents a feasible conversion resection strategy for patients with initially unresectable hepatocellular carcinoma: A retrospective study
por: Yi, Yong, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_98s0vh10g308c3qs2jnhp802ve